CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 420 filers reported holding CRISPR THERAPEUTICS AG in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,579,572 | -17.4% | 34,800 | +2.2% | 0.02% | -41.4% |
| Q2 2023 | $1,912,353 | +1.4% | 34,064 | -26.6% | 0.03% | -49.1% |
| Q4 2022 | $1,886,201 | -57.0% | 46,401 | -30.9% | 0.06% | -57.1% |
| Q3 2022 | $4,386,000 | +230.0% | 67,120 | +207.1% | 0.13% | +183.0% |
| Q2 2022 | $1,329,000 | +4.8% | 21,854 | +8.2% | 0.05% | +6.8% |
| Q1 2022 | $1,268,000 | +203.3% | 20,200 | +266.1% | 0.04% | +144.4% |
| Q4 2021 | $418,000 | -46.6% | 5,518 | +14.1% | 0.02% | -21.7% |
| Q2 2021 | $783,000 | – | 4,837 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |